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The polyamines (PAs) spermidine, spermine, putrescine and cadaverine are an essential class of metabolites
found throughout all kingdoms of life. In this comprehensive review, we discuss their metabolism, their various
intracellular functions and their unusual and conserved regulatory features. These include the regulation of
translation via upstream open reading frames, the over-reading of stop codons via ribosomal frameshifting,
the existence of an antizyme and an antizyme inhibitor, ubiquitin-independent proteasomal degradation, a
complex bi-directional membrane transport system and a unique posttranslational modification—hypusina-
tion—that is believed to occur on a single protein only (eIF-5A). Many of these features are broadly conserved
indicating that PA metabolism is both concentration critical and evolutionary ancient. When PA metabolism is
disrupted, a plethora of cellular processes are affected, including transcription, translation, gene expression
regulation, autophagy and stress resistance. As a result, the role of PAs has been associated with cell growth,
aging, memory performance, neurodegenerative diseases, metabolic disorders and cancer. Despite
comprehensive studies addressing PAs, a unifying concept to interpret their molecular role is missing. The
precise biochemical function of polyamines is thus one of the remaining mysteries of molecular cell biology.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Polyamines (PAs) are small aliphatic polycations
widely distributed in nature. They were first de-
scribed in 1678 by Antonie van Leeuwenhoek in
seminal fluid, resulting in naming two of its members
spermine (Spm) and spermidine (Spd) (historical
perspective was reviewed in Refs. [1] and [2]). PAs
are present in all living organisms, with the most
common PAs being Spm, Spd and putrescine
(Put) [3], followed by cadaverine (Cad) and 1,3-dia-
minopropane (1,3-DAP) (Fig. 1). Between species,
however, PA concentration and composition do vary.
For instance, Escherichia coli contains high concen-
trations of Put, while in many other bacteria and
eukaryotes, Spd and Spm are present at higher
concentrations (reviewed in Refs. [4] and [5]). InAuthors. Published by Elsevier Ltd. T
rg/licenses/by/4.0/).fungi, Spm has not been detected, apart from in the
Saccharomycotina subphylum [5]. Cad, despite
being characterized in bacteria and plants, is of low
to zero abundance in most other species (reviewed
in Refs. [4], [6] and [7]). The ubiquity of PAs in cells
implies that their existence is important; when PAs
are depleted from the cell, an enormous number of
biological processes have shown to be affected.Biosynthesis of Polyamines
PAs are predominantly derived from the amino
acids ornithine (Orn) and methionine, while arginine
and lysine serve as alternative, secondary sources
of these metabolites (Fig. 2). The canonical biosyn-
thesis pathway begins with Orn decarboxylation, byhis is an open access article under the CC BY license
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Fig. 1. Common and biologically relevant polyamines
(PAs). Putrescine (Put), spermidine (Spd) and spermine
(Spm) are the most common biological PAs followed by
cadaverine (Cad) and 1,3-diaminopropane (1,3-DAP).
Under physiological pH, PAs are present in a cationic
form, a condition essential for function in cells.
3390 Review: Role of Polyamine Metabolites in the Cellornithine decarboxylase (ODC), to form Put. Spd and
Spm are formed from Put via addition of aminopropyl
groups. These are donated by the methionine
derivative: decarboxylated S-adenosylmethionine
(dcAdoMet) produced by S-adenosylmethionine de-
carboxylase (AdoMetDC). The addition of aminopro-
pyl groups is mediated by spermidine and spermine
synthases (SpdS and SpmS), (reviewed in Refs. [4],
[6] and [7]). Put can alternatively be synthesized from
arginine via arginine decarboxylase (ADC)
and agmatinase (Fig. 2) (reviewed in Refs. [4], [6]
and [7]). There are exceptions in which the canonical
pathway is not entirely present; here, organisms
use alternative pathways to synthesize PAs.
Such is the case for Arabidopsis thaliana and
Trypanosoma cruzi that lack an ODC gene [8, 9].
A. thaliana synthesizes Put solely via the ADC route
[9], whereas T. cruzi (the insect form) uptakes Put
and Cad present in the excreta of its host insect [10,
11].
The less common PA, Cad, is the product of lysine
decarboxylation. Lysine decarboxylases (LDCs)
have been identified in bacteria (E. coli, Vibrio sp.,
Lactobacillus sp.), cyanobacteria and plants (e.g.
leguminosae, solanaceae and gramineae) [12–15],
whereas for fungi and animal cells, no LDC gene
has been described. Nonetheless, Cad has
also been detected in some of these latter organ-
isms [16, 17]. ODC was suggested as the enzyme
responsible for synthesizing Cad in these cases [16,
18–20], but other biosynthesis pathways remain
plausible. Cad could be the starting molecule for aparallel pathway to Put, Spd and Spm due to the fact
that Cad derivatives N1-(aminopropyl)-Cad and
N1,N′-(bis-aminopropyl)-Cad have been detected
in E. coli and fungi [18, 19, 21].The Intriguing Fine-Tuning of Polyamine
Levels
Intracellular PA levels are tightly regulated in their
biosynthesis, catabolism and/ or transport. The
enzymes in PA metabolism are controlled via highly
specialized and unconventional mechanisms at the
level of transcription, translation and protein degra-
dation, involving several feedback loops controlled
by PA concentrations. These aforementioned fea-
tures are highly conserved throughout all kingdoms
of life, indicating that the regulation of PA levels is
highly critical for the cell.
Transcriptional and translational control of
ornithine decarboxylase (ODC)
ODC is in many species the limiting factor for the
biosynthesis of Put, Spd and Spm and its intracel-
lular concentrations are tightly controlled. ODC can
alter its activity in response to many different types of
cellular perturbation. For example, ODC activity is
induced in response to growth stimuli and has
elevated activity in cells infected by viruses and
under conditions of disease such as cancer [22–28].
The regulation of ODC starts at transcription. Best
studied in mammals, the Odc promoter contains
various elements that respond to several stimuli,
such as growth factors, hormones and tumor
promoters [29–32]. For ODC translation, regulation
is highly dependent on PA concentration (Fig. 3a).
An increase in intracellular PA levels leads to ODC
translation repression, whereas a decrease causes
translation activation. So far, it is not well understood
how this translation repression and activation by PAs
occurs.
In mammals, ODC mRNAs have a long 5′
untranslated region (UTR) that contains a strong
secondary structure (reviewed in Ref. [33]). The 5′
UTR contains two additional elements that cause a
reduction in efficiency of ODC mRNA translation: a
small functional upstream open reading frame
(uORF) (Fig. 3a) and a GC-rich sequence [34–36].
Mammalian ODC mRNA translation can also be
mediated by an internal ribosome entry site (IRES).
This allows for translation initiation even when
cap-dependent translation is blocked, as in mitosis
for instance [37].
The turnover of ODC is also controlled. ODC is
short-lived with a half-life of less than 1 h [38, 39]; in
eukaryotes, ODC degradation occurs via the 26S
proteasome; however, this process is independent
of ubiquitination (Fig. 3b) [40]. As most proteins are
Fig. 2. Polyamine metabolism. PAs are synthesized, catabolized and transported according to the requirements of the
cell. The main biosynthetic pathways of Spd and Spm involves formation of Put from Orn by ODC and the transfer of
aminopropyl groups to Put from the methionine derivative, dcAdoMet, by SpdS and SpmS. Arginine can be used as a
precursor of Put via its hydrolysis to Orn by arginase or alternatively, via its decarboxylation to agmatine by ADC. PAs can
be acetylated by SSAT and/or oxidized by PAOs and APAOs producing a PA, an amino aldehyde and H2O2. In addition to
the aforementioned PAs, Cad and 1,3-DAP are also produced. Cad is the product of lysine decarboxylation by LDC
whereas 1,3-DAP is the product of Spm and Spd oxidation by PAO. The transport systems in mammals, bacteria, plants,
yeast and trypanosomatids are shown. Abbreviations: Spd, spermidine; Spm, spermine; Put, putrescine; Orn, ornithine;
ODC, ornithine decarboxylase; dcAdoMet, decarboxylated S-adenosyl-L-methionine; SpdS, spermidine synthase; SpmS,
spermine synthase; ADC, arginine decarboxylase; PAs, polyamines; SSAT, spermidine/spermine acetyltransferase;
PAOs, polyamine oxidases; APAO, acetylated polyamine oxidase; Cad, cadaverine; 1,3-DAP, 1,3-diaminopropane; LDC,
lysine decarboxylase.
3391Review: Role of Polyamine Metabolites in the Cellubiquitinated prior to protein degradation, this
feature of ODC degradation is relatively unusual
[41]. Other proteins that are degraded in this
ubiquitin-independent way in eukaryotes include
thymidylate synthase, a human enzyme responsible
for the conversion of deoxyuridine monophosphate
into deoxythymidine monophosphate and Rpn4, a
Saccharomyces cerevisiae transcription factor that
activates proteasomal genes (reviewed in Ref. [41]).
One similarity between these proteins that may
explain their degradation independent of ubiquitin is
the presence of an unstructured domain recogniz-
able by the proteasome [41].
ODC degradation depends on a PA-activated
protein: antizyme (AZ), an “antienzyme for ODC”[42–44]. AZ has high affinity for ODC monomers and
the resulting interaction inhibits ODC dimerization and
thus activity [43]. In addition, AZ causes a conforma-
tional change in ODC leading to exposure of ODC's
unstructured C-terminus that is then recognized by the
proteasome [43]. AZ can therefore be considered as a
catalyst for ODC degradation [41, 45–47].
Unlike other organisms, the region of ODC
exposed and recognized by the proteasome in S.
cerevisiae is the N-terminus [48]. Despite sequence
divergence across different species, the degradation
of ODC continues to be independent of ubiquitina-
tion and accelerated by AZ. This would indicate that
this type of regulation is optimal for ODC regulation
[41].
Fig. 3. Ornithine decarboxylase (ODC) and antizyme (AZ) regulation. (a) ODC translation is repressed in the presence
of high levels of PAs. This is mediated by an uORF in the 5′ UTR of ODC mRNA that reduces ODC translation efficiency.
(b) When cellular levels of PAs are low, ODC is in its active dimer form and produces additional Put. Upon increased levels
of PAs, AZ binds to ODC and, as well as inactivating it, promotes ODC degradation via the 26S proteasome in an
ubiquitin-independent manner. AZ is inactivated by binding to AZi. (c) Hypothetical model of AZ regulation. AZ is translated
by two ORFs that are separated by a codon stop. The complete and functional AZ is translated by ribosomal frameshifting.
This is achieved by shifting the reading frame by one nucleotide in the stop codon of the first ORF, which allows the
translation of the second ORF. PAs promote an increase in ribosomal frameshifting efficiency. Downstream of the
frameshift site is localized a pseudoknot that may stimulate frameshifting. Abbreviations: ODC, ornithine decarboxylase;
PAs, polyamines; Put, putrescine; AZ, antizyme; AZi, antizyme inhibitor.
3392 Review: Role of Polyamine Metabolites in the CellThe regulation of polyamine synthesis through
antizyme (AZ) levels
Apart from ODC, AZ facilitates the degradation of
other proteins such as the human Aurora A kinase,
via the proteasome in an ubiquitin-independent
manner [49]. This enzyme is conserved from
bacteria to humans but is not described in plants
[50–52]. AZ levels are controlled by an unusual and
highly conserved translational mechanism. It is
encoded by two adjacent open reading frames
(ORFs) and ribosomal frameshifting is required to
generate a functional product. This frameshifting
consists of ribosomes reaching the last codon of the
first ORF (a stop codon), shifting one nucleotide and
continuing to read the second ORF in the +1 frame.
In this way, the UGA stop codon is over-read
(Fig. 3c). The +1 ribosomal frameshifting at the
stop codon is remarkably well conserved in many
eukaryotes, while other features of the sequence
evolved independently [51]. It is still unclear how thisframeshift occurs mechanistically, how it is induced
and, further, why such costly mechanisms are
required to control AZ abundance.
The efficiency of ribosomal frameshifting is con-
trolled by the levels of PAs and thus AZ is the center
of a homeostatic feedback loop. When PA levels
are high, the efficiency of ribosomal frameshifting
increases, resulting in higher levels of AZ, an
increased rate of ODC degradation and, finally,
reduced biosynthesis of PAs [53–55]. In mammals,
this feedback loop also leads to a lower PA uptake
from the extracellular environment [53–55]. Whether
PAs regulate the AZ ribosomal frameshift directly
or indirectly is still not clear. A recent study in
S. cerevisiae revealed that, in the absence of PAs,
the nascent AZ polypeptide inhibits its own synthe-
sis; furthermore, when PAs are present, they can
interact with the nascent peptide and prevent AZ
synthesis inhibition (Fig. 3c) [56]. PAs also bind to
the mammalian AZ, suggesting that this is a
conserved mechanism [56].
3393Review: Role of Polyamine Metabolites in the CellFurthermore, AZ is regulated byanAZ inhibitor (AZi)
(Fig. 3b). AZi is similar to ODC but is catalytically
inactive [57]. AZ has more affinity to the AZi than to
ODC; their subsequent interaction allows ODC to
dimerize, be activated and escape degradation
(Fig. 3b). Both AZ and AZi are degraded by
ubiquitin-dependent proteasome degradation; thus,
ODC activity can be controlled by ubiquitination.
Interestingly, in mammals, one of the three AZ
present, AZ 1, has an additional characteristic: it
possesses two alternative start codons. These two
start codons result in two isoforms of varying length.
Notably, the longer isoform which is expressed at
low levels is targeted to the mitochondria [58] and the
nucleus, where it concerts a yet unknown role [59, 60].
Polyamines and S-adenosylmethionine
decarboxylase (AdoMetDC)
AdoMetDC catalyzes the formation of dcAdoMet
[61] that acts as a donor of aminopropyl groups for
the synthesis of Spd and Spm from Put. This enzyme
is expressed at low levels and, in this way, does not
deplete the concentration of S-adenosylmethionine
(AdoMet) that is essential for methyl transfer
reactions [61]. AdoMetDC is synthesized as an
inactive proenzyme. To become active, the proen-
zyme undergoes an internal serinolysis, which
causes cleavage of the proenzyme into two subunits
(α and β) and also results in the formation of a
pyruvoyl group at the N-terminus of the α-subunit
(Fig. 4a) [62]. In mammals and yeast, Put stimulates
AdoMetDC self-processing and activation [63–65].
The major regulators of AdoMetDC are PA levels.
While Put positively regulates AdoMetDC, Spd
and Spm negatively regulate the enzyme (reviewed
in Ref. [61]). Increases in AdoMetDC levels have
shown to be associated with growth stimulation, for
example, during hormone treatment, tissue regen-
eration and cellular differentiation [66–68]. Although
regulation of AdoMetDC transcription is not yet clear,
translation is known to be mediated by uORFs. The
mammalian uORF that precedes the ORF for
AdoMetDC is located 14 nucleotides downstream
of the 5′ cap and encodes a hexapeptide: MAGDIS
[69]. During translation of MAGDIS, when the final
tRNA (for serine) encounters the ribosome, it causes
a ribosomal stall close to the uORF termination site,
making the AdoMetDC start codon inaccessible
(Fig. 4b) [70]. The stability of the bound tRNA-
peptide is specific for the peptide sequence, and
additionally, this stability increases with higher levels
of Spd and Spm [70, 71].
In plants, there are two uORFs that overlap by one
nucleotide, the 5′ “tiny” and the 3′ “small”. The 3′
small uORF represses translation of the AdoMetDC
ORF and is also affected by PA levels. It is
hypothesized that, in low concentrations of PAs,
the 5′ tiny uORF is translated and is able to inhibittranslation of the 3′ small uORF. This inhibition
would allow ribosomes to reach the initiation codon
of AdoMetDC and initiate its translation [72]. In high
concentrations of PAs, the 3′ small uORF is
translated and subsequently blocks access to the
AdoMetDC ORF. This is because the 5′ tiny uORF is
bypassed by either the translation initiation complex
or a ribosome -1 frameshifting that enables transla-
tion of the two ORFs [72].
Similar to ODC, AdoMetDC half-life is short (less
than 1 h), and in extreme cases such as in Crithidia
fasciculata, the turnover occurs in 3 min [73].
AdoMetDC turnover accelerates when concentra-
tions of Spd and Spm are high [67]. Degradation of
AdoMetDC by polyubiquitination via the proteasome
is accelerated when its pyruvoyl group is transami-
nated and transformed into alanine by its substrate
AdoMet [74]. This transformation is suggested to
induce a conformational change in this enzyme,
making its ubiquitination site more accessible and
thus more prone for degradation [61, 74]. Addition-
ally, besides transamination promoting AdoMetDC
degradation, this reaction has also shown to
inactivate its function [74].
Controlling Polyamine levels through catabo-
lism
In addition to their synthesis, PAs can be oxidized
and/or acetylated to maintain their cellular activity or
concentration (Fig. 2). Regulation of PA concentra-
tion is mediated by PA oxidases (PAOs) that can be
classified depending on their cofactor, flavin adenine
dinucleotide (FAD) or copper. Within the FAD-
containing enzymes fall acetylated polyamine
oxidase (APAO) [75–77], the PA oxidase PAO [7,
78, 79] and the spermine oxidase SpmO [7, 80, 81].
The substrates of PAO and APAO are nonacetylated
or acetylated PAs, respectively, O2 and H2O. Most
PAOs produce smaller PAs, an amino aldehyde and
H2O2 (Fig. 2). An exception is diamine oxidase
(DAO), a copper-containing enzyme that produces
ammonia in addition to H2O2 (Fig. 2) [82–85]. The
amino aldehydes produced can then be precursors
for amino acids such as β-alanine and gamma-
aminobutyric acid (GABA) and for several different
alkaloids (reviewed in Ref. [7]).
The acetylation of Spm or Spd is catalyzed by
spermidine/spermine acetyltransferase (SSAT) [86–
89].WhenSSAT is activated, it leads toPAacetylation
that subsequently reduces their positive charge,
preventing their interaction with other molecules [90].
These acetylated metabolites are then excreted
(reviewed in Ref. [90]) or oxidized by the above-
mentioned FAD-dependent APAO. These reactions
thus form a cycle that allows the cell to regulate Spd
and Spm cellular concentrations quickly [90].
In addition, cells have adapted other mechanisms
to regulate PA concentration at this stage [86, 90]. In
Fig. 4. Regulation of adenosylmethionine decarboxylase
(AdoMetDC). (a) AdoMetDC is synthesized as an inactive
proenzyme, which becomes active after an internal serino-
lysis and consequent cleavage into two subunits: α and β.
AdoMetDC enzymes can be classified into different groups
[64]. Class 1 comprises bacterial and archeal enzymes.
Enzymes of this group have oligomericα/β structures and are
divided into two subgroups, depending onwhether or not they
require Mg2+ as a cofactor (1a and 1b, respectively). Class 2
AdoMetDCs include enzymes from plants, fungi and mam-
mals and subdivides into three groups: group 2a comprises
the mammalian and yeast dimeric α/β AdoMetDC. In this
class, Put stimulates AdoMetDC self-processing, and al-
though it is far from the catalytic domain, the binding of Put
leads to its activation [66–68]. Group 2b includes plant
monomeric enzymes that do not require Put but instead
contain two arginine residues that mimic the role of Put.
Group 2c includes the parasitic Trypanosoma brucei enzyme
that is composed of the α/β subunits and a catalytically dead
paralogue named prozyme that is required for AdoMetDC
activity [246]. The species in which regulation of AdoMetDC
processing and activity ismadebyPut (group2a) havehigher
levels of Spd andSpm than Put, while in species in which this
type of regulation is absent, Put is likely the most abundant
PA [64]. Upon transamination, AdoMetDC loses its function
and is more prone for degradation via the polyubiquitination/
proteasome system. Degradation of AdoMetDC is acceler-
ated when cellular levels of Spd and Spm increase. (b)
Regulation of translation is known to be mediated by an
uORF. The mammalian uORF is located 14 nucleotides
downstream of the 5′ cap and encodes a hexapeptide:
MAGDIS.When this peptide is being synthesized, ribosomes
stall and block access to the AdoMetDC start codon. The
duration of the ribosome stalls increases with increasing Spd
and Spm levels. Abbreviations: AdoMetDC, adenosylmethio-
nine decarboxylase; Put, putrescine; Spd, spermidine; Spm,
spermine.
3394 Review: Role of Polyamine Metabolites in the Cellhuman cells, the SSAT gene contains a PA-respon-
sive element (PRE) in the 5′ regulatory region that
allows transcription to be regulated by PA concen-
tration [91]. Moreover, it was found that Nrf-2
(nuclear factor erythroid 2–related factor 2) binds
constitutively to PRE and when the levels of PAs are
high this complex interacts with another protein,
PA-modulated factor-1, to activate SSAT transcrip-
tion [92, 93]. This mechanism was only found in
tumor cells that are sensitive to synthetic
PA analogues, that is, cells that respond to these
compounds by upregulating SSAT and consequently
increasing PA catabolism. This indicates that different
cell types regulate SSAT dissimilarly [91–93].
SSAT expression can also be modulated during
RNA processing by alternative splicing. During its
splicing, the intron between exon 3 and exon 4 might
be retained. This intron contains multiple codon
stops, making this splice variant prone for degrada-
tion by nonsense-mediated mRNA decay [94]. There
is evidence that this splice variant can give rise to a
truncated SSAT protein. In the presence of high
levels of PAs or its analogues, the formation of this
alternative splice variant is decreased, leading to
increased SSAT activity and therefore PA acetyla-
tion [86, 95].
SSAT translation can increase drastically in the
presence of PAs or synthetic PA analogues [96, 97].
Contrary to other enzymes of the PA pathway, the 5′
or 3′ UTRs do not seem to have the same prominent
role in the translational regulation of SSAT [96, 97].
Nonetheless, one or two uORFs can be found
depending on the species [98]. Recently, a study
using a human embryonic kidney cell line revealed
that these uORFs were able to repress SSAT
translation [99]. In addition, the initiation region of
SSAT mRNA contains a stem–loop that is stabilized
by a specific isoform of a protein called nucleolin
[99]. This interaction subsequently results in SSAT
translation repression (Fig. 5a). PAs at high levels
promote the autocatalysis of nucleolin, which likely
causes a reduction in the stability of the stem–loop of
SSAT and in turn alleviates translation repression
(Fig. 5b) [99]. This would then lead to an increase in
PA catabolism and re-establishment of PA levels.
Finally, for degradation, SSAT is polyubiquitinated
and degraded by the 26S proteasome [100]. SSAT
has a very short half-life of approximately 20 min
[99], which can be extended in the presence of an
Spm analogue, such as N1N12-bis(ethyl)spermine
[99].
Controlling Polyamine levels through transport
PA transport has been detected in almost every
model organism. In bacteria and single cellular
eukaryotes, membrane transport systems are well
described (Fig. 2). E. coli imports PAs mainly by two
ABC (ATP binding cassettes) type transporters,
3395Review: Role of Polyamine Metabolites in the CellPotABCD and PotFGHI, that are Spd preferential
and Put specific, respectively [101, 102]. Moreover,
there are two uptake/antiporters known as PotE
(Orn or Lys/Put) and CadB (Lys/Cad) that uptake
Orn or Lys and excrete Put or Cad, respectively
[103–105]. These transporters are induced under
acidic conditions and also have an important role in
the cell's response to acidic stress [104, 105]. In
E. coli, studies have also shown a Spd exporter
(MdtJI) to be important for PA homeostasis since it is
capable of rescuing a SSAT knockout strain from the
toxicity caused by high levels of Spd [106].
Yeast, a model organism for single cell eukary-
otes, has at least 10 transmembrane proteins
capable of PA transport. There are four transporters
in the plasma membrane involved in the PA uptake:
Dur3, Sam3, Agp2 and Gap1 [107–109]. Dur3 and
Sam3 are predominantly responsible for PA import
[108, 110], while Uga4 dominates PA vacuolar
transport [111]. Conversely, yeast has four trans-Fig. 5. Mammalian regulation of spermidine/spermine
N1-acetyltransferase (SSAT). (a) SSAT translation is
repressed by one or two uORFs and a stem–loop in its
mRNA. The stem-loop is stabilized by a specific isoform of
nucleolin SSAT translation. (b) SSAT translation increases
with an increase in the cellular concentration of PAs or PA
analogues. As a consequence, nucleolin undergoes
autocatalysis that destabilizes the stem–loop and releases
translation repression. This causes an increase in PA
catabolism and re-establishment of PA levels. Abbrevia-
tions: SSAT, spermidine/spermine N1-acetyltransferase;
PAs, polyamines.porters (Tpo1–Tpo4) that function as PA efflux
pumps [7, 112–114]. Tpo1 and Tpo4 are responsi-
ble for the transport of Spd, Spm [115] and Put [116],
while Tpo2 and Tpo3 only recognize Spm [115].
Deletion of Tpo1, the best-studied PA transporter,
shows sensitivity toward high levels of PAs, while its
overexpression increases tolerance to excess PA
supplementation [117, 118]. Finally, there is also a
fifth transporter, Tpo5, that is localized in theGolgi or
post-Golgi secretory vesicles and is responsible for
the excretion of Put and less effectively of Spd [114].
PA transporters have also been studied in T. cruzi
and Leishmania major. Here, they transport Put,
Cad and Spd and share 41.3% identity [9, 10, 119,
120]. As T. cruzi lacks ODC, import of PA from
external sources is the only way T. cruzi can obtain
Put or Spd, highlighting the essentiality of PA
transport for such organisms.
PA-specific transport systems in mammals and
plants are less well understood. In mammals, no PA
transporter has yet been identified. It has been
suggested that such a PA transport system would
involve an endocytic mechanism (reviewed in Refs.
[103] and [121]). Moreover, it has been proposed that
transport systems with other functions such as SLC7
(Lys/Arg/Orn permeases), CCC9 (an inorganic ion
transporter) and OCT6 (cation/anion/zwitterion trans-
porter) could also be responsible for PA uptake
(reviewed in Ref. [121]). In Arabidopsis, PA transport
has been attributed to the LAT (L-type amino acid
transporter) family [122]. These LAT transporters,
particularly RMV1/LAT1/AtPUT3, PAR1/AtLAT4/
AtPUT2 and AtLAT3/AtPUT1, are 68–76% similar to
eachother and are localized in the plasmamembrane,
Golgi apparatus and endoplasmic reticulum, respec-
tively [122].The Role of Polyamines in the Cell
Polyamines in gene expression
PAs are important for gene expression due to their
ability to bind to nucleic acids and proteins; thus, these
molecules can stabilize and remodel the chromatin
structure (reviewed in Ref. [123]). For example, the
analysis of chromatin structure of nuclei isolated from
U-87 MG human brain tumor cells revealed upon PA
depletion by treatmentwith anODC inhibitor [α-difluor-
omethylornithine (DFMO)] chromatin condensation is
impaired [124].
DNA structural changes mediated by PAs have
also shown to modulate the rate of transcription. For
example, PAs enhance the affinity of the mammalian
estrogenic receptor (ER) for its response elements
(ERE) by promoting the transition of the B-DNA to
the Z-DNA conformation [125]. PAs can further
mediate the activation of c-MYC transcription by
3396 Review: Role of Polyamine Metabolites in the Cellmodifying the quadruplex structure (present in the
regulatory sequence of this gene) into an active
conformation [126]. PAs additionally promote the
binding between proteins and DNA. In vitro studies
using the herpes simplex virus I DNA-binding protein
ICP-4 demonstrated that physiological concentra-
tions of Spd and Spm increase the rate of
association of this protein to DNA [127].
Most PAs are bound to RNA as shown in bovine
lymphocytes, rat liver and E. coli (57.2%, 78.3% and
89.7% respectively for Spd bound RNA; Spm: 65.2%
and 85.2%, for rat liver and E. coli; Put: 47.9% for E.
coli), suggesting that one of the major roles of PAs is
related to structural changes in RNA [128]. It is
therefore highly probable that PAs have an essential
role in translation.
The “PA modulon” is comprised of a group of
genes that increase their translation in the presence
of PAs, which in certain cases is cased by an
increase of their transcription factors [129, 130].
Members of this modulon have been identified in E.
coli and eukaryotes in which intracellular PA
concentrations have been modified [129–131]. The
discovery and analysis of members of this modulon
have provided information on mechanisms by which
PAs can regulate translation. For example, in E. coli,
PAs can promote the initiation of translation of
mRNAs with distant Shine–Dalgarno sequences
[e.g., oppa, rpoN, FecI σ factor (σ18), Fis] by bringing
the Shine–Dalgarno and the initial codon closer
together enabling formation of the initiation com-
plex. This was observed in vitro by measuring the
fMet-tRNA bound to ribosomes and the sensitivity of
synthesized RNAs to RNases in the presence and
absence of PAs [131–133]. Moreover, PAs stimu-
late the interaction between inefficient initiation
codons, UUG and GUG, and the fMet-tRNA, which
enhance the translation of RNAs such as cya and
cra [128, 131, 134]. In eukaryotes, PAs increase
translation of CCT2, HNRP1 and PGAM1 in
mammary carcinoma F3A cells, and COX4 in
yeast by “ribosome shunting” [130, 135]. In this
translation mechanism the 40S ribosome bypasses
5′ UTR regions and secondary structures which
usually interfere with translation, to reach the start
codon [136].
PAs can also participate in the elongation ofmRNAs
with stop codons inside the coding sequence. Such is
the case in E. coli for the σ factor regulating general
stress response, rpoS (σ38).When the rpoSmRNA is
mutated and has a (UAG) stop in the 33rd position
PAs can stimulate the readthrough of this codon by
increasing the incorporation of Gln-tRNAsupE (a
suppressor tRNA) [67, 137].
PAs can also regulate the phosphorylation of
different factors involved in translation. Such is the
case for NIH3T3 mammalian cells in which the ODC
inhibitor, DFMO, promotes changes in the phos-
phorylation of the translation initiation factor eIF-2αand the translation repressor protein 4E-BP, subse-
quently leading to the gradual inhibition of translation
initiation [138].
Polyamines in cell proliferation
The importance of PAs for cell growth and
proliferation has been recognized for decades. In
1957, Kihara and Snell demonstrated that Spm and
Spd promote growth of Lactobacillus casei [139].
Later in the 1970s, it was described that the
concentration of PAs in sea urchin eggs can change
cyclically and, further, egg cleavage is severely
impaired when PA biosynthesis is inhibited [140,
141]. In bacteria, a decrease in Spd and Put
concentrations leads to a reduction in growth rate
[142, 143], while this causes a complete arrest of cell
proliferation in eukaryotes [143–148]. Curiously, for
S. cerevisiae, Spd or Spd is essential only under
aerobic conditions, which may imply that different
PAs are required under different metabolic condi-
tions [147]. Although PA depletion leads to a similar
outcome in cell proliferation for prokaryotes and
eukaryotes, it seems that PAs affect this process in
multiple ways. One explanation of PA involvement in
bacterial growth is stimulation of the translation of
transcription factors related to growth, such as OppA,
Cya and RpoS, which belong to the “PA modulon”
[129, 130, 132]. In eukaryotes, PAs play a putative
role in cell cycle progression. Here, the PA concen-
trations and the activities of ODC and AdoMetDC
changeaccording to the phaseof cell cycle [149–154].
Furthermore, PA-depleted cells are arrested in their
cell cycle; however, it is still debated whether this
occurs in G1, S or G2 or all of them [144, 145, 150,
155–160].
Another role of PAs in eukaryotic cell proliferation
is related to the use of Spd as a substrate for an
essential posttranslational modification named
hypusination. So far, this modification has only
been reported for one protein—the eukaryotic
translation initiation factor eIF-5A—on a specific
lysine residue [161–163] (reviewed in Ref. [164]).
Hypusination involves two consecutive and highly
conserved reactions. First, deoxyhypusine synthase
(Dys1 in S. cerevisiae and DHPS in humans)
transfers the 4-aminobutyl moiety of Spd to the
ε-amino group of a specific lysine residue in the
eIF-5A precursor protein, generating the intermedi-
ate deoxyhypusine. This is followed by conversion of
deoxyhypusine into hypusine by deoxyhypusine
hydroxylase (Lia1 in S. cerevisiae and DOHH in
humans) activating eIF-5A [165].
Hypusine has been associated with cell prolifera-
tion since both eIF-5A and its hypusination are
essential for eukaryotes. For instance, in budding
yeast, deletion of both eIF-5A homologues (Hyp2
and Anb2) is lethal [164, 166, 167], as well as the
deletion of the deoxyhypusine synthase [168, 169].
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for degradation) in a yeast strain deleted for both
eIF-5A homologues showed that, upon eIF-5A
depletion, cell cycle is arrested [170]. Mutating the
eIF-5A lysine target of hypusination in yeast also
leads to loss of viability, confirming that hypusine is
required for the essential function of eIF-5A. It has
been proposed that the major function of Spd in
yeast is to serve as a substrate for hypusine
modification [171, 172]. In Caenorhabditis elegans
and Drosophila melanogaster the absence of DOHH
is lethal. [173–175]. In mice, the homozygous
deletion of eIF-5A-1 or DHPS is lethal [176].
Conversely, injection of a human liver cell line,
LO2, transfected with eIF-5A in mice caused tumor
formation [177]. Altogether, these observations
indicate that deoxyhypusine modification of eIF-5A
is essential for cell proliferation and survival of
eukaryotes.
Role of Polyamines in cellular stress
Cells are continuously exposed to different types
of stress, either by products of their own metabolism
or by environmental changes in reactive oxygen
species (ROS) levels, pH, osmotic pressure and
temperature. Extensive literature has demonstrated
that PAs are associated with the response and
protection to different types of stress which might
involve multiple PA properties. It is usually observed
that PA intracellular concentrations change during
exposure to stress. Moreover, modification of PA
concentrations either by exogenous addition or
chemical/ genetic methods can influence the sensi-
tivity of cells to stress (reviewed in Refs. [5] and [6]).
An example of this is the accumulation of Put during
osmotic stress in rat hepatoma cell cultures and
plants. In rats, this effect is due to an increase in
ODC activity caused by a decrease in the stability of
the regulatory enzyme of ODC, AZ [see The
regulation of polyamine synthesis through antizyme
(AZ) levels] [178]. In plants, when osmotic stress
occurs, Put accumulates to toxic levels due to an
increase in ADC activity [179, 180], resulting in
chlorophyll loss and senescence [181]. Treatment
with Spm protects cells from these toxic effects [181]
by inhibiting ADC proenzyme posttranslational acti-
vation and therefore ADC activity [182]. This modifi-
cation mediated by Spm suggests that ADC is
regulated at the posttranslational level during osmotic
stress [179, 181].
PAs have several other functions in the cell for
stress protection. This includes scavenging of ROS
[183–187], binding to membrane transport proteins
[188–190] and regulating expression of proteins
related to the stress response [191–196]. PAs can
function as ROS scavengers as they are polycationic
under physiological pH [183–185]. In vitro studies
show that PAs can function as scavengers of alkyl,hydroxyl and peroxyl radicals (by Cad, Put, Spd and
Spm) and superoxide (by Spd and Spm) using
physiological concentrations [183–185]. Indeed,
Spm was one of the most efficient ROS scavengers
[183–185] for protecting DNA from oxidative stress
[183].
Spm prevents the induction of the mitochondrial
permeability transition in rat liver mitochondria, by
maintaining the reduced state of glutathione (GSH)
and the sulfhydryl groups of thiols responsible for the
opening of the mitochondrial permeability pore [186].
Conversely, a study in fibroblasts lacking Spm
suggests that this PA and Spd protect cells from
H2O2, but by a different mechanism to GSH [187].
Another function of PAs during stress is to regulate
the expression of genes associated with the cell's
response and defense mechanisms. For example, in
E. coli, Put and Spd positively regulate the transcrip-
tion of stress-related transcription factors OxyR
(peroxide detoxification), SoxRS (superoxide radical
response) and RpoS (general stress) (reviewed in
Ref. [197]). This leads to the expression of down-
stream targets such as ahpC (alkyl hydroperoxide
reductase), katG (catalase/hydroperoxidase I) and
katE (hydroperoxidase II) [192, 193]. In yeast,
overexpression of the PA exporter, Tpo1, leads to
sensitivity to H2O2 and prevents the induction of
canonical stress proteins including Sod1, Hsp70,
Hsp90 and Hsp104. In addition to this phenotype,
Tpo1 -overexpressing cells have a prolonged oxidan-
t-induced cell cycle arrest, supporting the hypothesis
that these cells are less efficient in responding to
stress. It thus appears that an exact concentration of
PAs is critical for cells to mount the general stress
response [191].
Consistently, Spm appears to protect Arabidopsis
fromheat stressby increasing the expression of stress
response genes [194]. Transcriptomic analysis has
revealed information on the targets of PAs during the
stress response, suggesting new mechanisms by
which PAs can protect cells from stress. For example,
the pretreatment of tomatoes with Spd before heat
shock promoted an increase in expression of signal
transduction genes (e.g., calmodulin, serine/threonine
protein kinase) along with genes related to PA
biosynthesis pathway, hormone pathways, etc.
[195]. Moreover, the analysis of transcriptome data
from transgenic Arabidopsis containing different
intracellular concentrations of Put and Spm, revealed
that PAs are involved in stress signaling through
Ca2+, as well as through interactions with pathways
related to abscisic acid [196].
PAs further contribute to osmotic stress protection,
by functioning as “osmolytes” (reviewed in Ref.
[198]). E. coli excrete Put to compensate for charge
alterations during this type of stress [199]. Put
treatment of tobacco plants 1 h before osmotic
stress induced by polyethylene glycol, prevents
water loss from cells [200]. PAs also contribute to
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regulating the influx of Na+ and the efflux of K+ [201].
For example, in plants, the levels of Spm reached
under salt stress modulate the activity of Ca2+
channels, avoiding changes in Na+/K+ balance
[188].
Other function of PAs during stress can be related
to their binding capacity to proteins. Put, Cad, Spd
and Spm can bind to porins (OmpF and OmpC) in
E. coli, which are membrane proteins that function as
channels, inhibiting porin activity [189]. In particular,
this inhibition helps cells counteract the acidic and
osmotic stress conditions [190, 202].
Finally, a well-described mechanism in which a PA
is involved in the stress response is the role of Cad in
E. coli under acidic pH stress. This low pH causes an
activation of the transcriptional factor, cadC, from the
operon cadAB, which encodes for the inducible
lysine decarboxylase, cadA, and the Lys/Cad anti-
porter, cadB [203]. The proposed mechanism
involved in the acidic stress response includes (i)
the consumption of a proton by lysine decarboxylase
for the synthesis of Cad [4], (ii) the excretion of this
diamine by cadB [105] and finally (iii) the partial
inhibition of porins by Cad. This latter mechanism
has been proposed to control the influx/efflux of
substances to allow cells to adapt to the acidic stress
[202].
Polyamines in human disease
Only one genetic disease, the Snyder-Robinson
syndrome, has been directly linked to a genetic
defect in the PA biosynthesis pathway [204]. This
disease is a rare X-linked mental retardation disorder
caused by mutations in the gene that encodes Spm
synthase. Mutations in this enzyme reduce the levels
of Spm in lymphocytes and fibroblasts, leading to
deregulated Spd/Spm ratios. Further, apart from
mental retardation, this PA imbalance causes many
additional symptoms such as osteoporosis, facial
asymmetry and hypotonia [204].
Due to the importance of PAs in so many
molecular mechanisms, the number of human
diseases that are associated with PAs is consider-
able. The list continuously increases as PAs are
repeatedly found to be deregulated in metabolomics
studies. PAs have known to be associated with
cancer for more than 45 years, since Russel and
Snyder observed increased ODC activity in tumors
[205]. Since then, mounting evidence strongly
supports the role of PAs in cancer. For example,
PAs have increased abundance in urine and blood of
many cancer patients relative to healthy individuals
[206, 207]. Additionally, ODC is found increased in
many cancers [208]. ODC is a target of the
oncogene MYC [209] and is itself a potential
oncogene as its overexpression can transform
mammalian cell lines alone or together with otheroncogenes [210–212]. Moreover, a polymorphism in
intron 1 of ODC is considered a risk factor for colon
cancer [213]. Transgenic mice models overexpress-
ing ODC in skin showed that ODC can lead to the
formation of spontaneous skin tumors, confirming in
vitro cell results [214]. Studies with these models
have also shown that reducing the levels of PAs may
limit tumorigenesis [215, 216]. Other players of the
PA pathway have also been associated with cancer.
For example, high levels of SpmO were detected in
several cancer types [217, 218], and in vivo studies
in mice suggest that AZ (Fig. 3) can function as a
tumor suppressor [219].
Despite the strong association of PAs with cancer,
attempts to use this pathway as a therapeutic target
have failed so far. Several drugs targeting different
steps in the PA metabolic pathway have been
developed, but their efficacy in treating cancer
largely falls short of clinical success. Initial tests
with DFMO, an inhibitor of ODC, were promising,
appearing to be cytostatic or at least to slow down
growth in mammalian cells; further, DFMO revealed
anticancer activity in mice models [220, 221].
Conveniently, DFMO is approved by the Food and
Drug Administration, to treat African trypanosomia-
sis (sleeping sickness), which has facilitated broader
tests [222]. However, neither alone nor in combina-
tion with other agents was DFMO clinically effective.
To overcome these caveats, an attempt is currently
being undertaken to find synthetic PA analogues that
(i) do not replace the natural PAs functionally, (ii) are
taken up by cells competing with the import of natural
PAs and (iii) have the capacity to decrease the PA
levels by increasing their catabolism [223]. More-
over, despite observations that PA levels are higher
in blood and urine in cancer patients, it has still not
been confirmed whether PAs can be used as a
prognostic marker [224]. Due to these setbacks, the
authors speculate that, for developing a successful
PA therapeutic agent, it will first be required to
elaborate which biological role PAs play in cancer
(and in cells in general) so that the cancer relevant
functions can be specifically targeted.
Furthermore, PAs have been associated with
aging and neurodegeneration. In several organisms,
including yeast and humans, the levels of PAs
decrease with age. Remarkably, restoring their
levels is beneficial [225, 226]. Supplemented Spd
increased the l i fespan of S . cerevis iae ,
D. melanogaster and human peripheral blood
mononuclear cells [225]. It was recently shown that
feeding D. melanogaster with Spd prevents age-re-
lated memory decline, most likely as a result of
enhanced autophagy [227]. In addition, Spm pre-
vents lipopolysaccharide-induced memory deficit in
mice via the ionotropic glutamate receptor GluN2B
[228].
Unlike observations made for aging, in neurode-
generative diseases such as Parkinson's disease
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increased levels.Metabolic profiling of serumsamples
of PD patients suggested that alteration of PA
metabolism can be used to predict cases of rapid
progression [229]. In another study, PD patients were
found to have higher concentrations of Put, Cad,
acetylated derivatives of Cad and Spd (N1-acetyl-Cad
and N1-acetyl-Spd) and lower levels of Spd in the
cerebrospinal fluid. In red blood cells of PD patients,
Put levels are decreased and Spd and Spm levels are
increased [230]. Similar to these results from PD,
metabolic profiling of brains of AD patients revealed
elevated levels of Put, Spd, Spm and acetylated Spd
and Spm [231].
In in vitro studies, Spd accelerated misfolding and
aggregation of α-synuclein (associated with PD
[232]), while aggregates of amyloid-β (associated
with AD) were potentiated by Put, Spd and Spm
[233]. In addition, Spm enhanced α-synuclein
toxicity in a PD yeast model [234]. Furthermore,
PAs together with glutamyl residues can be incor-
porated into proteins, such as neuronal tubulin, by
transglutaminases (TG) forming the irreversible
posttranslational modification γ-glutamylamine
[235–240]. Abnormal TG activity is hypothesized to
contribute to the pathogenesis of neurodegenerative
diseases, by contributing to formation and stabiliza-
tion of proteinaceous aggregates [235–240].
Whether the increase in PA levels is a cause or
consequence of these pathologies is still unclear.
However, PAs have also shown to induce autophagy
[225, 241] to protect cells from stress thus, potentially,
they could be neuroprotective and this could be the
reason why PAs are increased in neurodegenerative
diseases. On the other hand, an increase in PAs is
cytotoxic and can lead to increased formation of toxic
metabolites including aldehydes and H2O2 [242, 243].
Lastly, the increase of PAs in PD and AD could simply
be due to levels of their enzymes increasing as a result
of proteasomal impairment, a hallmark of these
diseases [244]. Despite these initial observations,
additional studies, with in vivomodels, are required to
understand if aggregation promoted by PAs is
neuroprotective or contributes to neurotoxicity.Concluding Remarks
PAs are a fundamental class of positively
charged metabolites ubiquitous in nature. PAs are
involved in several cellular processes including
transcription, translation, stress protection and
metabolism; subsequently, they are found to be
important for growth, aging and many diseases
such as cancer and neurodegeneration. The role of
PAs i s anc i en t , a nd bo t h me t abo l i sm
and concentration levels are tightly regulated at
distinct stages. The regulation of PA levels involves
multiple, unique and unusual conserved mecha-nisms, implying a fundamental importance of
maintaining PAs at the correct cellular balance
and concentration. A general concept that would
unify these findings, for instance, a common
chemical or physical process that can only operate
by the presence of a PA, has not yet been
presented. Solving the puzzle about the role of
PAs might thus reveal a key feature in cellular and
molecular biology that for now remains to be
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